Dose response in prostate cancer with 8-12 years' follow-up.
暂无分享,去创建一个
Alexandra L Hanlon | A. Hanlon | E. Horwitz | G. Hanks | Gerald E Hanks | B. Epstein | Barry Epstein | Eric M Horwitz
[1] G. Hanks,et al. Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate. , 2001, International journal of radiation oncology, biology, physics.
[2] C. Reddy,et al. Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6, and pretreatment prostate-specific antigen < or = 10). , 2001, International journal of radiation oncology, biology, physics.
[3] P. Maingon,et al. Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results. , 2000, International journal of radiation oncology, biology, physics.
[4] T E Schultheiss,et al. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. , 1999, The cancer journal from Scientific American.
[5] A. Markoe,et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. , 2000, International journal of radiation oncology, biology, physics.
[6] T E Schultheiss,et al. Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML. , 1996, International journal of radiation oncology, biology, physics.
[7] D. Cox. Regression Models and Life-Tables , 1972 .
[8] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[9] H. Sandler,et al. 3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review. , 2000, International journal of radiation oncology, biology, physics.
[10] Dennis Mah,et al. Characteristics and quality assurance of a dedicated open 0.23 T MRI for radiation therapy simulation. , 2002, Medical physics.
[11] G Starkschall,et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] A. Hanlon,et al. Dose selection for prostate cancer patients based on dose comparison and dose response studies. , 2000, International journal of radiation oncology, biology, physics.
[13] M. Bolla. Adjuvant Hormonal Treatment with Radiotherapy for Locally Advanced Prostate Cancer , 1998, European Urology.
[14] D. Grignon,et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. , 2001, International journal of radiation oncology, biology, physics.
[15] James D. Cox,et al. Consensus statement: Guidelines for PSA following radiation therapy , 1997 .
[16] W. R. Lee,et al. 2 Conformal technique dose escalation in prostate cancer: improved cancer control with higher doses in patients with pretreatment PSA 10 ngm/ml , 1995 .
[17] C C Ling,et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.
[18] R J Myerson,et al. Late effects of radiation therapy on the gastrointestinal tract. , 1995, International journal of radiation oncology, biology, physics.
[19] T E Schultheiss,et al. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect. , 1996, International journal of radiation oncology, biology, physics.
[20] H. Sandler,et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. , 1997, International journal of radiation oncology, biology, physics.
[21] A. Hanlon,et al. Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer. , 2000, International journal of radiation oncology, biology, physics.
[22] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[23] T E Schultheiss,et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. , 1999, International journal of radiation oncology, biology, physics.
[24] M. Roach,et al. Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. , 1996, The Journal of urology.
[25] A. Hanlon,et al. Defining the optimal radiation dose with three‐dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques , 2001, Cancer.